Skip to content

Clinical trials

Fatty Liver trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fatty Liver Country / region: South Korea Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20131
20141
20161
20181
20192
20201
20233
20246
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting5
Active, not recruiting4
Unknown status2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Seoul National University Hospital7
89bio, Inc.2
Chuncheon Sacred Heart Hospital2
So Yeon Kim2
Chonbuk National University Hospital1
Eli Lilly and Company1
GlaxoSmithKline1
Jae Won Choi1
Jong Keon Jang1
Seoul National University Boramae Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fatty Liver21
Non-alcoholic Fatty Liver Disease8
Fibrosis4
Liver Diseases4
Digestive System Diseases3
Hepatitis B, Chronic3
Liver Cirrhosis3
Diabetes Mellitus, Type 22
Metabolic Diseases2
Diabetes Mellitus1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.